Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533032) titled 'Dose-Response Effect of Phosphatidylserine on eSport Performance' on April 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Lindenwood University
Condition:
Cognitive Function
Gaming Performance
Intervention:
Dietary Supplement: Placebo
Dietary Supplement: Phosphatidylserine (100 mg)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 15, 2021
Target Sample Size: 80
Countries of Recruitmen...